Evida Biosciences
PrivateLast Round
Early Funding
Oct 11, 2024
Total Funding Raised
$42M
Company Overview
Evida Biosciences is a biotechnology company that focuses on the development of pharmaceutical ingredients and therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evida Biosciences Comparables
Compare Evida Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solstice Oncology | 80% | |
| Phanes Therapeutics | 76% | |
| SRT Therapeutics | 74% |
Evida Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 11, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2024
$42M raised in early funding.
Evida Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evida Biosciences's valuation, stock price, and market status.
Is Evida Biosciences a public or private company?
Evida Biosciences is a private company.
What is the current stock price of Evida Biosciences?
Evida Biosciences is a private company with no public stock price. Caplight tracks Evida Biosciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Evida Biosciences worth (valuation)?
Valuation information for Evida Biosciences is not publicly available.
Can I buy Evida Biosciences stock?
Evida Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evida Biosciences's last funding round?
Evida Biosciences's most recent funding round was Early Funding on October 11, 2024.
Who are the main investors in Evida Biosciences?
Investor information for Evida Biosciences is not publicly disclosed.
Will Evida Biosciences IPO soon?
No public IPO plans have been announced for Evida Biosciences.
How can I track Evida Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evida Biosciences's secondary market activity and sign up for updates.